350 related articles for article (PubMed ID: 9404252)
1. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
2. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
Trappe HJ
Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
[TBL] [Abstract][Full Text] [Related]
3. [10 years of therapy with implantable defibrillators--observation in 353 patients].
Trappe HJ; Wenzlaff P; Klein H; Pfitzner P; Fieguth HG; Kielblock B; Lichtlen PR
Z Kardiol; 1995 Mar; 84(3):222-31. PubMed ID: 7732715
[TBL] [Abstract][Full Text] [Related]
4. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
[TBL] [Abstract][Full Text] [Related]
5. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
Osswald S; Candinas R; Fuhrer J
Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
[TBL] [Abstract][Full Text] [Related]
6. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function.
Trappe HJ; Wenzlaff P; Pfitzner P; Fieguth HG
Heart; 1997 Sep; 78(3):243-9. PubMed ID: 9391285
[TBL] [Abstract][Full Text] [Related]
8. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
[TBL] [Abstract][Full Text] [Related]
9. [The implantable cardioverter-defibrillator: the Portuguese experience].
Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
[TBL] [Abstract][Full Text] [Related]
10. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
11. [The importance of the underlying disease for outcome of patients with implanted automatic defibrillators].
Trappe HJ; Fieguth HG; Klein H; Wenzlaff P; Weber-Conrad O; Schöhl W; Kielblock B; Lichtlen PR
Med Klin (Munich); 1993 Jun; 88(6):362-70. PubMed ID: 8336663
[TBL] [Abstract][Full Text] [Related]
12. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.
van Rees JB; Borleffs CJ; Thijssen J; de Bie MK; van Erven L; Cannegieter SC; Bax JJ; Schalij MJ
Europace; 2012 Jan; 14(1):66-73. PubMed ID: 21920909
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of elderly recipients of implantable cardioverter defibrillators.
Grimm W; Stula A; Sharkova J; Alter P; Maisch B
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S134-8. PubMed ID: 17302690
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter defibrillator in maintenance hemodialysis patients with ventricular tachyarrhythmias: a single-center experience.
Ito I; Kono K; Shinbo G; Tadokoro K; Abe C; Takemura N; Iemura T; Matsuhashi N; Nakano N; Ota S; Ishimitsu T; Matsuoka H
Hemodial Int; 2009 Jan; 13(1):48-54. PubMed ID: 19210278
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with implantable cardioverter-defibrillators. Experiences from Skejby hospital during the period 1989-1994].
Nielsen JC; Christiansen EH; Mortensen PT; Pedersen AK
Ugeskr Laeger; 1996 Feb; 158(8):1068-72. PubMed ID: 8638339
[TBL] [Abstract][Full Text] [Related]
19. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
20. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
